Neurochemistry is the study of the chemical and physical processes that take place in the brain and nervous system. This interdisciplinary field of study brings together aspects of biochemistry, physiology, molecular biology, and pharmacology to study the mechanisms by which these systems operate. Neurochemists research how electrical signals in neurons create chemical reactions, how chemicals are produced and released in neurons, and how these chemicals interact with each other to carry out necessary processes for normal brain function. Neurons are highly complex cells that use a variety of chemicals to communicate with each other and carry out their many functions. Neurochemicals, such as neurotransmitters, are involved in many essential biological processes, including hormone regulation, muscle contraction, appetite, and sleep. By understanding the chemical messages within neurons, neurochemists may uncover how they regulate these processes. For example, research has shown that neurotransmitters can have both excitatory and inhibitory effects on neurons, allowing them to either speed up or slow down their reactions. Neurochemists can also study how chemical and physical changes in the environment lead to changes in the brain and nervous system. For example, drugs can alter the level of neurotransmitters in the brain, altering normal functioning and leading to conditions such as addiction. Similarly, physical injuries or diseases can alter normal neuronal activity, leading to impairments in the body’s functioning. By understanding these processes, neurochemists hope to develop treatments that can reverse the effects of these conditions or even prevent them from happening in the first place.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States